PH30109A - Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same - Google Patents

Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same

Info

Publication number: PH30109A
Authority: PH; Philippines
Prior art keywords: production; crystalline hydrate; triazolylthiomethylthio; hydroclhloride; cephalosporin
Prior art date: 1992-07-31

Application number

PH46601A

Other languages

English (en)

Inventor

Hisanori Takahashi

Yutaka Ide

Original Assignee

Shionogi & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-31

Filing date

1993-07-29

Publication date

1996-12-27

1993-07-29 Application filed by Shionogi & Co filed Critical Shionogi & Co

1996-12-27 Publication of PH30109A publication Critical patent/PH30109A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PH46601A 1992-07-31 1993-07-29 Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same PH30109A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP20496592		1992-07-31

Publications (1)

Publication Number	Publication Date
PH30109A true PH30109A (en)	1996-12-27

Family

ID=16499234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH46601A PH30109A (en)	1992-07-31	1993-07-29	Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same

Country Status (23)

Country	Link
US (1)	US5407929A (pl)
EP (1)	EP0581552B1 (pl)
KR (1)	KR100245938B1 (pl)
CN (1)	CN1037683C (pl)
AT (1)	ATE165360T1 (pl)
AU (1)	AU657866B2 (pl)
BR (1)	BR9303235A (pl)
CA (1)	CA2101502A1 (pl)
DE (1)	DE69318077T2 (pl)
ES (1)	ES2115725T3 (pl)
FI (1)	FI933391A7 (pl)
GR (1)	GR3026699T3 (pl)
HU (1)	HU219637B (pl)
IL (1)	IL106516A (pl)
MX (1)	MX9304611A (pl)
NO (1)	NO303734B1 (pl)
NZ (1)	NZ248285A (pl)
PH (1)	PH30109A (pl)
PL (2)	PL172835B1 (pl)
RU (1)	RU2118959C1 (pl)
TW (1)	TW307769B (pl)
UA (1)	UA37181C2 (pl)
ZA (1)	ZA935529B (pl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1953162T1 (sl) *	2001-02-24	2012-09-28	Boehringer Ingelheim Pharma	Ksantinski derivati, njihova priprava in njihova uporaba kot zdravila
AT413282B (de) *	2002-02-01	2006-01-15	Sandoz Ag	Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
KR20030076759A (ko) *	2002-03-21	2003-09-29	주식회사 엘지생명과학	신규 세팔로스포린 화합물 및 그의 제조 방법
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US6727277B1 (en)	2002-11-12	2004-04-27	Kansas State University Research Foundation	Compounds affecting cholesterol absorption
WO2004072040A1 (en)	2003-02-12	2004-08-26	Ciba Specialty Chemicals Holding Inc.	Crystalline forms of pitavastatin calcium
MXPA05010083A (es)	2003-03-27	2005-11-23	Basilea Pharmaceutica Ag	Cefalosporina en forma cristalina.
US7501426B2 (en) *	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de)	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
PE20080251A1 (es) *	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
BRPI0711558A2 (pt) *	2006-05-04	2011-11-08	Boeringer Ingelheim Internat Gmbh	polimorfos
NZ600126A (en) *	2007-08-17	2013-12-20	Boehringer Ingelheim Int	Purine derivatives for use in the treatment of fap-related diseases
PE20140960A1 (es)	2008-04-03	2014-08-15	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) *	2008-06-03	2010-02-23	Boehringer Ingelheim Int	Tratamiento de nafld
BRPI0916997A2 (pt)	2008-08-06	2020-12-15	Boehringer Ingelheim International Gmbh	Inibidor de dpp-4 e seu uso
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR101657960B1 (ko) *	2008-08-15	2016-09-20	베링거 인겔하임 인터내셔날 게엠베하	Ｆａｂ-관련 질환의 치료에 사용하기 위한 푸린 유도체
AU2009290911A1 (en)	2008-09-10	2010-03-18	Boehringer Ingelheim International Gmbh	Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (en)	2008-12-23	2011-11-02	Boehringer Ingelheim International GmbH	Salt forms of organic compound
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EA034869B1 (ru)	2009-11-27	2020-03-31	Бёрингер Ингельхайм Интернациональ Гмбх	Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
MX341025B (es)	2010-05-05	2016-08-04	Boehringer Ingelheim Int Gmbh *	Terapia de combinacion.
PH12012502524A1 (en)	2010-06-24	2014-02-10	Boehringer Ingelheim Int	Diabetes therapy
US9034883B2 (en)	2010-11-15	2015-05-19	Boehringer Ingelheim International Gmbh	Vasoprotective and cardioprotective antidiabetic therapy
EP3517539B1 (en)	2011-07-15	2022-12-14	Boehringer Ingelheim International GmbH	Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
US20130303554A1 (en)	2012-05-14	2013-11-14	Boehringer Ingelheim International Gmbh	Use of a dpp-4 inhibitor in sirs and/or sepsis
JP6224084B2 (ja)	2012-05-14	2017-11-01	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en)	2014-02-28	2016-12-27	Boehringer Ingelheim International Gmbh	Medical use of a DPP-4 inhibitor
CN109310697A (zh)	2016-06-10	2019-02-05	勃林格殷格翰国际有限公司	利格列汀和二甲双胍的组合

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES475573A1 (es) *	1977-07-12	1980-01-16	Fujisawa Pharmaceutical Co	Un procedimiento para preparar nuevos compuestos de cefem
IE65926B1 (en) *	1990-07-19	1995-11-29	Shionogi & Co	Thioalkylthio cephalosporin derivatives

1993
- 1993-07-26 ES ES93305864T patent/ES2115725T3/es not_active Expired - Lifetime
- 1993-07-26 AT AT93305864T patent/ATE165360T1/de not_active IP Right Cessation
- 1993-07-26 DE DE69318077T patent/DE69318077T2/de not_active Expired - Fee Related
- 1993-07-26 TW TW082105942A patent/TW307769B/zh active
- 1993-07-26 EP EP93305864A patent/EP0581552B1/en not_active Expired - Lifetime
- 1993-07-27 US US08/097,205 patent/US5407929A/en not_active Expired - Fee Related
- 1993-07-27 UA UA93003172A patent/UA37181C2/uk unknown
- 1993-07-28 CA CA002101502A patent/CA2101502A1/en not_active Abandoned
- 1993-07-28 AU AU44227/93A patent/AU657866B2/en not_active Ceased
- 1993-07-28 HU HU9302194A patent/HU219637B/hu not_active IP Right Cessation
- 1993-07-28 IL IL106516A patent/IL106516A/en not_active IP Right Cessation
- 1993-07-29 PL PL93299870A patent/PL172835B1/pl unknown
- 1993-07-29 NZ NZ24828593A patent/NZ248285A/en unknown
- 1993-07-29 PH PH46601A patent/PH30109A/en unknown
- 1993-07-29 FI FI933391A patent/FI933391A7/fi unknown
- 1993-07-29 PL PL93317972A patent/PL172830B1/pl unknown
- 1993-07-30 BR BR9303235A patent/BR9303235A/pt not_active Application Discontinuation
- 1993-07-30 RU RU93047027/04A patent/RU2118959C1/ru not_active IP Right Cessation
- 1993-07-30 KR KR1019930014742A patent/KR100245938B1/ko not_active Expired - Fee Related
- 1993-07-30 ZA ZA935529A patent/ZA935529B/xx unknown
- 1993-07-30 NO NO932745A patent/NO303734B1/no unknown
- 1993-07-30 MX MX9304611A patent/MX9304611A/es unknown
- 1993-07-31 CN CN93117437A patent/CN1037683C/zh not_active Expired - Fee Related
1998
- 1998-04-23 GR GR980400753T patent/GR3026699T3/el unknown

Also Published As

Publication number	Publication date
KR100245938B1 (ko)	2000-04-01
FI933391L (fi)	1994-02-01
ZA935529B (en)	1994-02-24
HUT68602A (en)	1995-06-28
PL172835B1 (pl)	1997-12-31
EP0581552B1 (en)	1998-04-22
EP0581552A3 (en)	1994-06-01
TW307769B (pl)	1997-06-11
PL299870A1 (en)	1994-02-07
NO303734B1 (no)	1998-08-24
ATE165360T1 (de)	1998-05-15
RU2118959C1 (ru)	1998-09-20
HU9302194D0 (en)	1993-10-28
MX9304611A (es)	1994-02-28
EP0581552A2 (en)	1994-02-02
US5407929A (en)	1995-04-18
DE69318077T2 (de)	1998-10-29
NO932745D0 (no)	1993-07-30
FI933391A0 (fi)	1993-07-29
NZ248285A (en)	1994-07-26
AU657866B2 (en)	1995-03-23
AU4422793A (en)	1994-02-03
BR9303235A (pt)	1994-03-01
IL106516A0 (en)	1993-11-15
DE69318077D1 (de)	1998-05-28
IL106516A (en)	1998-06-15
PL172830B1 (pl)	1997-12-31
FI933391A7 (fi)	1994-02-01
CA2101502A1 (en)	1994-02-01
KR940005636A (ko)	1994-03-22
GR3026699T3 (en)	1998-07-31
UA37181C2 (uk)	2001-05-15
ES2115725T3 (es)	1998-07-01
CN1037683C (zh)	1998-03-11
CN1089948A (zh)	1994-07-27
NO932745L (no)	1994-02-01
HU219637B (hu)	2001-06-28

Publication	Publication Date	Title
AU657866B2 (en)	1995-03-23	Triazolylthiomethylthio cephalosporin hydrochloride, its crystalline hydrate and the production of the same
AU616838B2 (en)	1991-11-07	N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro- 2h-benzopyran or dihydrobenzodioxin)carboxamide derivatives
AU6787690A (en)	1991-06-13	Amino acid derivatives
AU4236889A (en)	1990-04-12	Imidazoline derivative and preparation thereof
MY104937A (en)	1994-07-30	Cephalosporin derivatives and processes for their preparation
IL91001A0 (en)	1990-02-09	N-alkyl derivatives of antibiotic bu-3608 complex and pharmaceutical compositions containing them
EP0342423A3 (en)	1991-04-17	Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics
NO174258C (no)	1994-04-06	Analogifremgangsmåte for fremstilling av terapeutisk aktive, krystallinske cefemsyreaddisjonssalter
EP0416810A3 (en)	1992-04-01	Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates
NZ235130A (en)	1993-05-26	Cephalosporin derivatives; oxygen and carbon analogues thereof; pharmaceutical compositions; methods of preparation and treatment
NZ218227A (en)	1989-01-06	Cephalosporin derivatives and pharmaceutical compositions
AU619395B2 (en)	1992-01-23	Cephalosporin derivatives and processes for their preparation
AU6059094A (en)	1994-10-27	Active compound from a sponge